Suchergebnisse - "Mu, Guangyan"

PubPharm (85)

21

Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects

enthalten in: Clinical drug investigation | 2022

von Xiang, Q. | Liu, Z. | Mu, G. | +10

22

Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects

enthalten in: Clinical drug investigation | 2022

von Xiang, Q. | Liu, Z. | Mu, G. | +10

23

Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects

enthalten in: Clinical drug investigation | 2022

von Xiang, Q. | Liu, Z. | Mu, G. | +10

24

Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor : a systematic review with qualitative and quantitative meta-analysis

enthalten in: BMC cardiovascular disorders | 2022

von Xie, Q. | Xiang, Q. | Liu, Z. | +7

25

Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis

enthalten in: BMC cardiovascular disorders | 2022

von Xie, Q. | Xiang, Q. | Liu, Z. | +7

26

Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis

enthalten in: BMC cardiovascular disorders | 2022

von Xie, Q. | Xiang, Q. | Liu, Z. | +7

27

Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation : a systematic review and meta-analysis

enthalten in: European journal of clinical pharmacology | 2022

von Mu, G. | Zhang, H. | Liu, Z. | +9

28

SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population

enthalten in: Frontiers in genetics | 2022

von Xie, Q. | Li, Y. | Liu, Z. | +9

29

Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran : A Multicenter Study

enthalten in: Frontiers in cardiovascular medicine | 2022

von Liu, Z. | Mu, G. | Xie, Q. | +4

30

Genetic variations in relation to bleeding and pharmacodynamics of dabigatran in Chinese patients with nonvalvular atrial fibrillation : A nationwide multicentre prospective cohort study

enthalten in: Clinical and Translational Medicine | 2022

von Xiang, Q. | Xie, Q. | Liu, Z. | +15